Fremont, United States
Q'Apel Medical, a healthcare startup founded in 2016, is revolutionizing neurovascular interventions with its novel access device technology. The company's slogan, "In the simplest sense, we’re a company that creates solutions," aptly captures its mission to address unmet clinical needs in emergency situations such as strokes.
Q'Apel Medical's groundbreaking approach to designing and developing lifesaving technology has garnered significant attention from investors, evidenced by its recent $17.13M Venture Round investment on May 9, 2024. This substantial infusion of capital underscores the market's confidence in the company's innovative solutions and their potential to make a meaningful impact in the field of neurovascular care.
Headquartered in the United States, Q'Apel Medical is well-positioned to leverage its proximity to leading healthcare and technology hubs, fostering collaborations and advancements in the burgeoning field of neurovascular interventions.
With a clear focus on delivering timely and effective technology, Q'Apel Medical is poised to solidify its position as a key player in the neurovascular space, offering hope to clinicians and patients alike in moments of dire need.
